RMD vs. SYK
Compare and contrast key facts about ResMed Inc. (RMD) and Stryker Corporation (SYK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RMD or SYK.
Correlation
The correlation between RMD and SYK is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
RMD vs. SYK - Performance Comparison
Key characteristics
RMD:
0.42
SYK:
0.74
RMD:
0.80
SYK:
1.11
RMD:
1.12
SYK:
1.14
RMD:
0.39
SYK:
1.02
RMD:
1.77
SYK:
3.14
RMD:
8.27%
SYK:
5.02%
RMD:
33.87%
SYK:
22.12%
RMD:
-61.60%
SYK:
-58.63%
RMD:
-14.85%
SYK:
-4.53%
Fundamentals
RMD:
$35.29B
SYK:
$142.75B
RMD:
$8.90
SYK:
$7.78
RMD:
27.04
SYK:
48.07
RMD:
1.43
SYK:
2.15
RMD:
7.03
SYK:
6.22
RMD:
6.34
SYK:
6.90
RMD:
$5.02B
SYK:
$23.22B
RMD:
$2.94B
SYK:
$14.76B
RMD:
$1.71B
SYK:
$5.32B
Returns By Period
In the year-to-date period, RMD achieves a 7.62% return, which is significantly higher than SYK's 6.04% return. Over the past 10 years, RMD has underperformed SYK with an annualized return of 15.65%, while SYK has yielded a comparatively higher 16.52% annualized return.
RMD
7.62%
13.46%
-2.48%
14.02%
9.52%
15.65%
SYK
6.04%
4.95%
1.79%
16.19%
15.95%
16.52%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RMD vs. SYK — Risk-Adjusted Performance Rank
RMD
SYK
RMD vs. SYK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RMD vs. SYK - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 0.87%, more than SYK's 0.86% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | 0.87% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% |
SYK Stryker Corporation | 0.86% | 0.90% | 1.02% | 1.16% | 0.97% | 0.96% | 1.02% | 1.23% | 1.13% | 1.31% | 1.52% | 1.34% |
Drawdowns
RMD vs. SYK - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.60%, which is greater than SYK's maximum drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for RMD and SYK. For additional features, visit the drawdowns tool.
Volatility
RMD vs. SYK - Volatility Comparison
ResMed Inc. (RMD) has a higher volatility of 10.66% compared to Stryker Corporation (SYK) at 7.10%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RMD vs. SYK - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RMD vs. SYK - Profitability Comparison
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a gross profit of 766.41M and revenue of 1.29B. Therefore, the gross margin over that period was 59.3%.
SYK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Stryker Corporation reported a gross profit of 3.74B and revenue of 5.87B. Therefore, the gross margin over that period was 63.8%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported an operating income of 426.27M and revenue of 1.29B, resulting in an operating margin of 33.0%.
SYK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Stryker Corporation reported an operating income of 837.00M and revenue of 5.87B, resulting in an operating margin of 14.3%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ResMed Inc. reported a net income of 365.04M and revenue of 1.29B, resulting in a net margin of 28.3%.
SYK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Stryker Corporation reported a net income of 654.00M and revenue of 5.87B, resulting in a net margin of 11.2%.